» Articles » PMID: 33194736

Autophagy Takes Center Stage As a Possible Cancer Hallmark

Overview
Journal Front Oncol
Specialty Oncology
Date 2020 Nov 16
PMID 33194736
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer remains one of the leading causes of death worldwide, despite significant advances in cancer research and improvements in anticancer therapies. One of the major obstacles to curing cancer is the difficulty of achieving the complete annihilation of resistant cancer cells. The resistance of cancer cells may not only be due to intrinsic factors or factors acquired during the evolution of the tumor but may also be caused by chemotherapeutic treatment failure. Conversely, autophagy is a conserved cellular process in which intracellular components, such as damaged organelles, aggregated or misfolded proteins and macromolecules, are degraded or recycled to maintain cellular homeostasis. Importantly, autophagy is an essential mechanism that plays a key role in tumor initiation and progression. Depending on the cellular context and microenvironmental conditions, autophagy acts as a double-edged sword, playing a role in inducing apoptosis or promoting cell survival. In this review, we propose several scenarios in which autophagy could contribute to cell survival or cell death. Moreover, a special focus on novel promising targets and therapeutic strategies based on autophagic resistant cells is presented.

Citing Articles

Hypoxia-Inducible Factor 1-Alpha (HIF-1α) and Cancer: Mechanisms of Tumor Hypoxia and Therapeutic Targeting.

Basheeruddin M, Qausain S Cureus. 2024; 16(10):e70700.

PMID: 39493156 PMC: 11529905. DOI: 10.7759/cureus.70700.


Programmed cell death in tumor immunity: mechanistic insights and clinical implications.

Wang M, Yu F, Zhang Y, Li P Front Immunol. 2024; 14:1309635.

PMID: 38283351 PMC: 10811021. DOI: 10.3389/fimmu.2023.1309635.


Inhibition of Autophagy Aggravates L. Skin Extracts-Induced Apoptosis in Cancer Cells.

Tsai C, Huang H, Lin K, Liu J, Chen G, Yeh Y Int J Mol Sci. 2024; 25(2).

PMID: 38279345 PMC: 10816816. DOI: 10.3390/ijms25021345.


Pectin a multifaceted biopolymer in the management of cancer: A review.

Picot-Allain M, Neergheen V Heliyon. 2023; 9(11):e22236.

PMID: 38058641 PMC: 10696011. DOI: 10.1016/j.heliyon.2023.e22236.


The Promise of Piperine in Cancer Chemoprevention.

Benayad S, Wahnou H, El Kebbaj R, Liagre B, Sol V, Oudghiri M Cancers (Basel). 2023; 15(22).

PMID: 38001748 PMC: 10670142. DOI: 10.3390/cancers15225488.


References
1.
Gudipaty S, Conner C, Rosenblatt J, Montell D . Unconventional Ways to Live and Die: Cell Death and Survival in Development, Homeostasis, and Disease. Annu Rev Cell Dev Biol. 2018; 34:311-332. PMC: 6791364. DOI: 10.1146/annurev-cellbio-100616-060748. View

2.
Kiraz Y, Adan A, Yandim M, Baran Y . Major apoptotic mechanisms and genes involved in apoptosis. Tumour Biol. 2016; 37(7):8471-86. DOI: 10.1007/s13277-016-5035-9. View

3.
Han H, Li J, Feng X, Zhou H, Guo S, Zhou W . Autophagy-related genes are induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid via the activation of cathepsin B in human breast cancer cells. Oncotarget. 2017; 8(32):53352-53365. PMC: 5581115. DOI: 10.18632/oncotarget.18410. View

4.
Rosenfeld M, Ye X, Supko J, Desideri S, Grossman S, Brem S . A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme. Autophagy. 2014; 10(8):1359-68. PMC: 4203513. DOI: 10.4161/auto.28984. View

5.
Seo J, Seong D, Nam Y, Hwang C, Lee S, Lee C . Beclin 1 functions as a negative modulator of MLKL oligomerisation by integrating into the necrosome complex. Cell Death Differ. 2020; 27(11):3065-3081. PMC: 7560833. DOI: 10.1038/s41418-020-0561-9. View